Table 1. Clinicopathological characteristics of six patients with distal cholangiocarcinoma.
No. | Gender | Age | Histological differentiation | T | N | M | TNM stagea | CA19-9 (U/mL) | Positive lymph nodes | Total lymph nodes | Perineuronal invasion |
1 | Male | 70 | Moderate | T2 | N0 | M0 | IIA | 40.30 | 0 | 37 | No |
2 | Male | 62 | Moderate-poor | T2 | N0 | M0 | IIA | 26.47 | 0 | 14 | Yes |
3 | Male | 64 | Moderate | T3 | N1 | M1 | IV | 643.47 | 1 | 15 | Yes |
4 | Male | 69 | Moderate | T3 | N0 | M0 | IIB | 74.04 | 0 | 21 | Yes |
5 | Male | 53 | Moderate | T3 | N0 | M0 | IIB | 9.16 | 0 | 14 | Yes |
6 | Female | 56 | Poor | T3 | N1 | M0 | IIB | 177.21 | 1 | 29 | Yes |
aTNM stage is based on the 8th edition of the American Joint Committee on Cancer.
CA 19-9, carbohydrate antigen 19-9.